Total retroperitoneal lipectomy improves prognosis in patients with primary retroperitoneal liposarcoma: a comparative study
2024

Total Retroperitoneal Lipectomy Improves Prognosis in Patients with Primary Retroperitoneal Liposarcoma

Sample size: 81 publication Evidence: moderate

Author Information

Author(s): Gao Haicheng, Liu Shibo, Li Wenjie, Zou Boyuan, Miao Chengli

Primary Institution: Peking University International Hospital

Hypothesis

This study aims to explore the safety and efficacy of total retroperitoneal lipectomy compared to traditional complete resection for primary retroperitoneal liposarcoma.

Conclusion

Total retroperitoneal lipectomy appears to be a safe procedure that enhances survival outcomes in patients with primary retroperitoneal liposarcoma.

Supporting Evidence

  • The TRL group demonstrated improved recurrence-free survival and overall survival compared to the CR group.
  • Post-operative morbidity occurred in 30.9% of cases, with no significant difference between the two surgical approaches.
  • Subgroup analysis revealed that TRL improved RFS in dedifferentiated liposarcoma patients.

Takeaway

Doctors found that a special surgery called total retroperitoneal lipectomy helps patients with a type of cancer called retroperitoneal liposarcoma live longer and healthier.

Methodology

The study retrospectively analyzed patients treated for primary retroperitoneal liposarcoma, comparing outcomes between those who underwent total retroperitoneal lipectomy and those who had traditional complete resection.

Potential Biases

Inherent biases due to the retrospective design and potential variability in treatment across different surgical specialties.

Limitations

The study's retrospective nature may introduce biases, and the low incidence of retroperitoneal liposarcoma limits the number of specialized centers for standardized studies.

Participant Demographics

Patients included had unilateral primary retroperitoneal liposarcoma, with a mix of well-differentiated and dedifferentiated liposarcoma.

Statistical Information

P-Value

P=0.002 for RFS, P=0.030 for OS

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fonc.2024.1488143

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication